Elanco Animal Health Incorporated (NYSE:ELAN) Q3 2025 Earnings Call Transcript
Elanco Animal Health Incorporated (NYSE:ELAN) Q3 2025 Earnings Call Transcript November 5, 2025Elanco Animal Health Incorporated beats earnings expectations.
Elanco Animal Health Inc (ELAN)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Millennium Management Israel Englander | 5,612,831 | $113,042,416 | +47% | 0.05% |
| 2. | Citadel Investment Group Ken Griffin | 4,843,380 | $97,545,673 | -65% | 0.01% |
| 3. | Freestone Grove Partners Todd Barker And Daniel Morillio | 3,841,422 | $77,366,239 | -1% | 0.58% |
| 4. | Woodline Partners Michael Rockefeller And Karl Kroeker | 3,669,503 | $73,903,790 | +16% | 0.35% |
| 5. | Holocene Advisors Brandon Haley | 2,093,054 | $42,154,108 | -28% | 0.1% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $10.20 | 10,000 | $102,000.00 | 111,459 | 2025-03-11 | Filing | |
| $10.90 | 10,000 | $109,000.00 | 101,459 | 2025-03-07 | Filing | |
| $10.90 | 25,000 | $272,557.50 | 210,000 | 2025-03-05 | Filing | |
| $14.85 | 3,500 | $51,974.30 | 81,094 | 2024-08-22 | Filing | |
| $13.01 | 100,000 | $1,300,610.00 | 145,000 | 2024-08-12 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $29.84 | 54,500,000 | $1,626,367,200.00 | 18,446,429 | 2020-12-03 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 82,759,837 | $1,666,783,117 | 0.9% | |
| 2. | 65,357,380 | $1,316,297,631 | 0.07% | |
| 3. | 49,958,156 | $1,006,157,262 | 0.77% | |
| 4. | 48,586,708 | $978,536,298 | 0.01% | |
| 5. | 46,178,502 | $930,035,025 | 0.02% |
News See All
Elanco Animal Health Incorporated (ELAN) Joins S&P MidCap 400 Following Strong Q2 Growth and Product Ramp-Up
Elanco Animal Health Incorporated (NYSE:ELAN), a global leader in veterinary pharmaceuticals and biologics, continues to advance its mission of improving animal health and food safety through innovation...
10 Best Pharma Stocks to Buy According to Billionaires
Recently, President Trump wrote letters to 17 major pharmaceutical firms outlining the actions they should take to bring the prices of prescription pharmaceuticals in the United States down to "most favored...
Elanco Animal Health Incorporated (NYSE:ELAN) Q2 2025 Earnings Call Transcript
Elanco Animal Health Incorporated (NYSE:ELAN) Q2 2025 Earnings Call Transcript August 7, 2025Elanco Animal Health Incorporated beats earnings expectations.
Elanco (ELAN) Jumps 19.7% to Record High on Earnings Boost
This followed the release of its earnings performance that saw the company swing to a net income of $11 million from a $50 million net loss in the same period last year.
Elanco Animal Health Incorporated (NYSE:ELAN) Q1 2025 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Welcome to Elanco Animal Health First Quarter 2025 Earnings Conference Call.
10 Best Cheap Stocks to Buy Under $10
On April 21, Tom Lee, Fundstrat CIO, co-founder, and managing partner, joined 'Squawk Box' on CNBC to discuss the latest market trends and stated that the market may be past peak uncertainty despite the...
12 Stocks That Are About to Explode
Despite the current headwinds and uncertainty (which also caused heightened volatility in the last 2 weeks), there are indications that the recent US stock market correction was short-lived, and the market...
8 Best Pet Stocks to Buy According to Billionaires
The pet industry is expected to continue growing in the coming years, driven by changing consumer preferences and innovative trends.
Here’s Why Elanco Animal Health Incorporated (ELAN) Declined in Q4
Hardman Johnston Global Advisors, an investment management company, released its “Hardman Johnston Global Equity” fourth quarter 2024, investor letter. A copy of the letter can be downloaded here.